Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024

Rhea-AI Summary

Eton Pharmaceuticals, Inc. will report its fourth quarter and full year 2023 financial results on March 14, 2024. The management will host a conference call to discuss the results and answer questions from investors.

DEER PARK, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report fourth quarter and full year 2023 financial results on Thursday, March 14, 2024. Management will host a conference call and live audio webcast to discuss these results at 4:30 p.m. ET (3:30 p.m. CT).

Register* (Audio Only) Click here

In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.

The live webcast can be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.

* Conference call participants should register to obtain their dial-in and passcode details. Please be sure to register using a valid email address.

About Eton Pharmaceuticals

Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has four FDA-approved rare disease products: ALKINDI SPRINKLE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals

FAQ

When will Eton Pharmaceuticals report its fourth quarter and full year 2023 financial results?

Eton Pharmaceuticals will report its fourth quarter and full year 2023 financial results on Thursday, March 14, 2024.

What time will the conference call to discuss the financial results take place?

The conference call to discuss the financial results will take place at 4:30 p.m. ET (3:30 p.m. CT).

How can investors participate in the live webcast?

Investors can access the live webcast on the Investors section of Eton's website at https://ir.etonpharma.com/.

Where can participants find the archived webcast after the event?

The archived webcast will be available on Eton's website approximately two hours after the completion of the event and for 30 days thereafter.

How can conference call participants obtain dial-in and passcode details?

Conference call participants should register to obtain their dial-in and passcode details. Registration using a valid email address is required.